Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
XYL

XYL - Xylem Inc-NY Stock Price, Fair Value and News

127.27USD-0.69 (-0.54%)Market Closed

Market Summary

XYL
USD127.27-0.69
Market Closed
-0.54%

XYL Alerts

  • 6 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)

XYL Stock Price

View Fullscreen

XYL RSI Chart

XYL Valuation

Market Cap

30.8B

Price/Earnings (Trailing)

50.53

Price/Sales (Trailing)

4.18

EV/EBITDA

36.51

Price/Free Cashflow

36.76

XYL Price/Sales (Trailing)

XYL Profitability

Operating Margin

36.90%

EBT Margin

8.34%

Return on Equity

4.83%

Return on Assets

3.05%

Free Cashflow Yield

2.72%

XYL Fundamentals

XYL Revenue

Revenue (TTM)

7.4B

Rev. Growth (Yr)

40.64%

Rev. Growth (Qtr)

2.02%

XYL Earnings

Earnings (TTM)

492.0M

Earnings Growth (Yr)

78.52%

Earnings Growth (Qtr)

75%

Breaking Down XYL Revenue

Last 7 days

-0.4%

Last 30 days

10.8%

Last 90 days

22.4%

Trailing 12 Months

16.6%

How does XYL drawdown profile look like?

XYL Financial Health

Current Ratio

1.76

Debt/Equity

0.22

Debt/Cashflow

0.37

XYL Investor Care

Dividend Yield

1.04%

Dividend/Share (TTM)

1.2

Shares Dilution (1Y)

34.11%

Diluted EPS (TTM)

2.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20235.7B6.1B6.8B7.4B
20225.2B5.2B5.3B5.5B
20215.0B5.2B5.2B5.2B
20205.1B5.0B4.9B4.9B
20195.2B5.3B5.3B5.2B
20184.9B5.0B5.1B5.2B
20174.0B4.2B4.5B4.7B
20163.7B3.7B3.7B3.8B
20153.8B3.8B3.7B3.7B
20143.9B3.9B3.9B3.9B
20133.7B3.7B3.8B3.8B
20123.8B3.8B3.8B3.8B
20113.4B3.6B3.7B3.8B
2010003.0B3.2B
20090002.8B

Tracking the Latest Insider Buys and Sells of Xylem Inc-NY

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 05, 2024
yarkadas hayati
sold
-579,879
127
-4,547
svp & president, eu, wi & gls
Mar 01, 2024
aulick rodney
acquired
212,508
127
1,661
svp & president, wss
Mar 01, 2024
mcshane geri-michelle
acquired
239,504
127
1,872
vp, controller & cao
Mar 01, 2024
yarkadas hayati
sold
-3,112,280
127
-24,478
svp & president, eu, wi & gls
Mar 01, 2024
yarkadas hayati
acquired
1,921,080
97.9741
19,608
svp & president, eu, wi & gls
Mar 01, 2024
capers dorothy trefon
acquired
181,291
127
1,417
svp & general counsel
Mar 01, 2024
cerwinka franz
sold
-170,897
127
-1,341
svp & pres, aws & bus trnsform
Mar 01, 2024
mcgann michael j.
sold (taxes)
-137,919
127
-1,078
svp & president americas & mcs
Mar 01, 2024
cerwinka franz
acquired
604,133
127
4,722
svp & pres, aws & bus trnsform
Mar 01, 2024
mcshane geri-michelle
sold (taxes)
-97,106
127
-759
vp, controller & cao

1–10 of 50

Which funds bought or sold XYL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 13, 2024
MONECO Advisors, LLC
new
-
223,574
223,574
0.04%
Mar 12, 2024
Spartan Planning & Wealth Management
new
-
104,754
104,754
0.11%
Mar 11, 2024
Wahed Invest LLC
added
8.06
121,908
462,815
0.13%
Mar 11, 2024
VANGUARD GROUP INC
added
0.67
671,483,000
3,207,680,000
0.07%
Mar 08, 2024
TRUST CO OF VERMONT
reduced
-2.23
140,839
757,749
0.05%
Mar 08, 2024
ICA Group Wealth Management, LLC
new
-
4,939
4,939
-%
Mar 06, 2024
SageView Advisory Group, LLC
new
-
303,599
303,599
0.01%
Mar 05, 2024
Fisher Asset Management, LLC
added
7.89
11,369,400
43,362,400
0.02%
Mar 04, 2024
TUCKER ASSET MANAGEMENT LLC
unchanged
-
817
4,003
-%
Mar 01, 2024
ROYAL LONDON ASSET MANAGEMENT LTD
added
2.75
2,409,630
10,704,600
0.03%

1–10 of 47

Are Funds Buying or Selling XYL?

Are funds buying XYL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own XYL
No. of Funds

Unveiling Xylem Inc-NY's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
aristotle capital management, llc
3.71%
8,951,632
SC 13G/A
Feb 13, 2024
vanguard group inc
11.63%
28,047,688
SC 13G/A
Jan 24, 2024
blackrock inc.
10.1%
24,255,217
SC 13G/A
Feb 14, 2023
aristotle capital management, llc
5.59%
10,076,810
SC 13G/A
Feb 09, 2023
vanguard group inc
11.67%
21,037,631
SC 13G/A
Jan 24, 2023
blackrock inc.
11.2%
20,207,719
SC 13G/A
Feb 14, 2022
aristotle capital management, llc
5.89%
10,627,194
SC 13G/A
Jan 27, 2022
blackrock inc.
10.0%
18,052,578
SC 13G/A
Jan 26, 2022
blackrock inc.
10.0%
18,052,578
SC 13G/A
Feb 16, 2021
price t rowe associates inc /md/
0.5%
944,169
SC 13G/A

Recent SEC filings of Xylem Inc-NY

View All Filings
Date Filed Form Type Document
Mar 11, 2024
144
Notice of Insider Sale Intent
Mar 08, 2024
144
Notice of Insider Sale Intent
Mar 08, 2024
8-K
Current Report
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading

What is the Fair Value of XYL?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Xylem Inc-NY)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
183.8B
68.0B
14.92% 83.49%
19.39
2.7
16.96% 2688.24%
177.2B
67.1B
10.85% 29.98%
17.15
2.64
12.84% 54.12%
41.9B
6.5B
6.39% 20.39%
31.93
6.36
7.26% 13.25%
39.0B
34.1B
12.37% 8.60%
46.41
1.14
21.34% -61.52%
12.5B
14.9B
-1.46% -0.69%
201.49
0.84
12.31% -81.65%
MID-CAP
9.3B
6.9B
10.82% 63.71%
60.72
1.34
5.64% 109.59%
6.6B
15.5B
11.76% 18.10%
47.62
0.43
12.59% -4.48%
5.8B
4.3B
6.48% 17.09%
31.09
1.34
19.51% -1.03%
4.0B
2.3B
5.04% 43.94%
24.91
1.72
2.90% -35.23%
2.5B
1.7B
7.02% 39.98%
18.09
1.46
11.63% 33.59%
SMALL-CAP
1.1B
1.4B
-11.75% -57.40%
17.74
0.81
-24.65% -34.19%
854.8M
56.2M
5.71% -69.42%
-0.88
23.85
-27.93% -23.21%
652.7M
527.6M
1.71% 19.68%
19.21
1.24
14.23% 56.70%
431.8M
135.4M
41.25% 149.65%
-26.33
3.19
-25.90% 65.37%
173.8M
99.2M
32.09% 9.94%
-14.19
1.75
-3.69% -37.37%

Xylem Inc-NY News

Latest updates
MarketBeat • 26 hours ago
Yahoo Finance • 07 Mar 2024 • 08:00 am
Markets Insider • 22 Feb 2024 • 01:29 pm
Yahoo Finance • 14 Feb 2024 • 08:00 am
Yahoo Finance • 07 Feb 2024 • 08:00 am
Yahoo Finance • 5 months ago

Xylem Inc-NY Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue2.0%2,1182,0761,7221,4481,5061,3801,3641,2721,3231,2651,3511,2561,3731,2201,1601,1231,3711,2961,3451,2371,386
Cost Of Revenue3.8%1,3621,3121,071902933856844805830793831766847759726714834787819763844
Gross Profit-1.0%756764651546573524520467493472520490526461434409537509526474542
  S&GA Expenses-5.1%466491446354315294314304301273304301292266288297288273294303293
  R&D Expenses-1.6%60.0061.0058.0053.0054.0047.0053.0052.0052.0049.0053.0050.0049.0045.0044.0049.0049.0044.0047.0051.0052.00
EBITDA Margin-4.5%0.12*0.12*0.10*0.11*0.11*0.10*0.13*0.13*0.14*0.14*0.13*0.11*---------
Interest Expenses0%14.0014.0012.009.0013.0012.0012.0013.0013.0021.0021.0021.0021.0022.0018.0016.0015.0016.0018.0018.0019.00
Income Taxes-269.7%-56.0033.0022.0027.0040.005.0024.0016.0013.0019.0025.0027.0010.0013.004.004.0060.00-77.0017.0015.00-46.00
Earnings Before Taxes13.5%21018511412618917.0013698.0012613313811415850.0035.0042.00178-12.0015694.00179
EBT Margin-8.3%0.08*0.09*0.07*0.08*0.08*0.07*0.09*0.09*0.10*0.10*0.09*0.07*---------
Net Income75.0%26615292.0099.0014912.0011282.0012982.0011387.0014837.0031.0038.0011865.0013979.00225
Net Income Margin-8.3%0.07*0.07*0.06*0.07*0.06*0.06*0.08*0.08*0.08*0.08*0.07*0.06*---------
Free Cashflow22.0%45537328.00-19.00362202113-81.00220112232-26.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets1.3%16,11215,90516,0977,9407,9528,1068,1898,2198,2768,1518,7858,5458,7508,4488,4447,5917,7107,5157,6747,4687,222
  Current Assets6.4%3,8843,6513,7353,0103,0123,1913,1743,1183,1603,0573,6233,4013,5233,3113,3012,4622,4502,2632,2582,0812,094
    Cash Equivalents44.5%1,0197057088379441,1861,1131,1171,3491,2551,8401,6881,8751,4021,577739724453383275296
  Inventory-5.7%1,0181,0801,143857799837852804700679642596558582595573539580604617595
  Net PPE3.3%1,1691,1321,144631630585608636644618626627657633635628658641661653656
  Goodwill6.1%7,5877,1497,1082,7382,7192,6372,7142,7822,7922,8162,8412,8312,8542,7952,8202,7902,8392,8112,9992,9882,976
Liabilities-0.5%5,9365,9646,1874,3514,4494,8844,9865,0135,0505,0495,7365,5995,7745,5735,5794,7704,7434,6204,7684,6604,440
  Current Liabilities4.0%2,2052,1202,2821,4941,5901,9291,9511,9201,3911,3141,9591,8441,9561,2801,3731,5841,5011,4611,5371,4411,389
  Long Term Debt0.7%2,2682,2532,2671,8811,8801,8801,8791,8782,4402,4552,4662,4602,4843,0533,0312,0312,0402,0302,0512,0442,051
    LT Debt, Non Current0.7%2,2682,2532,2671,8811,8801,8801,8791,8782,4402,4552,4662,4602,4843,0533,0312,0312,0402,0302,0512,0442,051
Shareholder's Equity2.4%10,1669,9309,9103,5893,4943,2223,2033,2063,2263,2063,0492,9462,9762,8752,8652,8212,9672,8952,9062,8082,782
  Retained Earnings7.7%2,6012,4162,3442,3312,2922,1972,2382,1812,1542,0922,0291,9671,9301,8281,8381,8541,8661,7911,7701,6741,639
  Additional Paid-In Capital0.4%8,5648,5298,4952,1522,1342,1232,1112,0992,0892,0772,0632,0492,0372,0212,0122,0041,9911,9831,9751,9621,950
Shares Outstanding-9.9%217241193180180180180180180180180180---------
Minority Interest-9.1%10.0011.0011.0011.009.007.008.008.008.009.009.009.008.008.009.009.0010.009.0012.0012.0014.00
Float---26,900---14,000---22,600---11,600---14,000--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations22.0%455,000373,00028,000-19,000362,000202,000113,000-81,000220,000112,000232,000-26,000370,000275,000181,000-2,000388,000245,000123,00083,000198,000
  Share Based Compensation-19.4%14,50018,00016,00012,0009,00010,0009,0009,0008,0008,0008,0009,0007,0003,0008,0008,0006,0007,0007,0009,0007,000
Cashflow From Investing-78.0%-89,000-50,000-452,000-37,000-68,000-39,000-41,000-43,000-70,000-44,000-38,000-31,000157,000-238,000-40,000-48,000-46,000-39,000-69,000-77,000-64,000
Cashflow From Financing71.9%-86,000-306,000298,000-63,000-580,000-52,000-52,000-106,000-49,000-644,000-47,000-115,000-77,000-224,000687,00087,000-78,000-124,00054,000-29,000-235,000
  Dividend Payments0%80,00080,00079,00060,00054,00053,00055,00055,00051,00050,00051,00051,00046,00047,00047,00048,00043,00044,00043,00044,00038,000
  Buy Backs1400.0%15,0001,0001,0008,000--1,00051,000--1,00067,000-1,000-60,0001,000--39,0001,000

XYL Income Statement

2023-12-31
Consolidated Income Statements - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue$ 7,364$ 5,522$ 5,195
Cost of revenue4,6473,4383,220
Gross profit2,7172,0841,975
Selling, general and administrative expenses1,7571,2271,179
Research and development expenses232206204
Restructuring and asset impairment charges76297
Operating income652622585
Interest expense495076
U.K. pension settlement expense0(140)0
Other non-operating income, net3370
(Loss) Gain on sale of businesses(1)12
Income before taxes635440511
Income tax expense268584
Net income$ 609$ 355$ 427
Earnings per share:   
Basic (in dollars per share)$ 2.81$ 1.97$ 2.37
Diluted (in dollars per share)$ 2.79$ 1.96$ 2.35
Basic (in shares)217,012180,217180,247
Weighted average common shares outstanding — Diluted218,180180,979181,526
Dividends declared per share (in usd per share)$ 1.32$ 1.20$ 1.12
Product   
Revenue$ 6,291$ 4,978$ 4,684
Cost of revenue3,8173,0022,831
Service   
Revenue1,073544511
Cost of revenue$ 830$ 436$ 389

XYL Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 1,019$ 944
Receivables, less allowances for discounts, returns and credit losses of $56 and $50 in 2023 and 2022, respectively1,6171,096
Inventories1,018799
Prepaid and other current assets230173
Total current assets3,8843,012
Property, plant and equipment, net1,169630
Goodwill7,5872,719
Other intangible assets, net2,529930
Other non-current assets943661
Total assets16,1127,952
Current liabilities:  
Accounts payable968723
Accrued and other current liabilities1,221867
Short-term borrowings and current maturities of long-term debt160
Total current liabilities2,2051,590
Long-term debt, net2,2681,880
Accrued post-retirement benefit obligations344286
Deferred income tax liabilities557222
Other non-current accrued liabilities562471
Total liabilities5,9364,449
Commitment and Contingencies (Note 19)
Common stock — par value $0.01 per share:  
Authorized 750.0 shares, issued 257.6 and 196.0 shares in 2023 and 2022, respectively32
Capital in excess of par value8,5642,134
Retained earnings2,6012,292
Treasury stock – at cost 16.0 shares and 15.8 shares in 2023 and 2022, respectively(733)(708)
Accumulated other comprehensive loss(269)(226)
Total stockholders’ equity10,1663,494
Non-controlling interest109
Total equity10,1763,503
Total liabilities and stockholders’ equity$ 16,112$ 7,952
XYL
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the Flygt, Godwin, Sanitaire, Leopold, Wedeco, and Xylem Vue brand names for the transportation and treatment of water. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, Xylem Vue, and Flojet brand names for residential and commercial building services, and industrial water applications. The Measurement & Control Solutions segment offers smart meters, networked communication devices, data analytics, test equipment, controls, sensor devices, software and managed services, and critical infrastructure services; and software and services, including cloud-based analytics, remote monitoring and data management, leak detection, condition assessment, asset management, and pressure monitoring solutions, as well as testing equipment. This segment sells its products under the Pure Technologies, Sensus, Smith Blair, WTW, Xylem Vue, and YSI brand names. The company markets and sells its products through a network of direct sales force, resellers, distributors, and value-added solution providers. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in May 2011. Xylem Inc. was incorporated in 2011 and is headquartered in Washington, District of Columbia.
 CEO
 WEBSITEwww.xylem.com
 EMPLOYEES22000

Xylem Inc-NY Frequently Asked Questions


What is the ticker symbol for Xylem Inc-NY? What does XYL stand for in stocks?

XYL is the stock ticker symbol of Xylem Inc-NY. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Xylem Inc-NY (XYL)?

As of Fri Mar 15 2024, market cap of Xylem Inc-NY is 30.77 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XYL stock?

You can check XYL's fair value in chart for subscribers.

What is the fair value of XYL stock?

You can check XYL's fair value in chart for subscribers. The fair value of Xylem Inc-NY is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Xylem Inc-NY is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for XYL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Xylem Inc-NY a good stock to buy?

The fair value guage provides a quick view whether XYL is over valued or under valued. Whether Xylem Inc-NY is cheap or expensive depends on the assumptions which impact Xylem Inc-NY's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XYL.

What is Xylem Inc-NY's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Mar 15 2024, XYL's PE ratio (Price to Earnings) is 50.53 and Price to Sales (PS) ratio is 4.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XYL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Xylem Inc-NY's stock?

In the past 10 years, Xylem Inc-NY has provided 0.138 (multiply by 100 for percentage) rate of return.